Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.781
+0.010 (1.31%)
At close: Dec 20, 2024, 4:00 PM
0.795
+0.014 (1.79%)
After-hours: Dec 20, 2024, 5:30 PM EST
Lucid Diagnostics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Lucid Diagnostics stock have an average target of 3.63, with a low estimate of 2.00 and a high estimate of 7.00. The average target predicts an increase of 364.79% from the current stock price of 0.78.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LUCD stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
Buy | 2 | 2 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 5 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.25 → $7 | Strong Buy | Maintains | $7.25 → $7 | +796.29% | Dec 9, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $3 → $2 | Buy | Maintains | $3 → $2 | +156.08% | Nov 15, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +284.12% | Nov 14, 2024 |
Needham | Needham | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +220.10% | Nov 14, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.5 → $7.25 | Strong Buy | Maintains | $7.5 → $7.25 | +828.30% | Sep 10, 2024 |
Financial Forecast
Revenue This Year
4.66M
from 2.43M
Increased by 91.80%
Revenue Next Year
11.14M
from 4.66M
Increased by 139.27%
EPS This Year
-1.11
from -1.26
EPS Next Year
-0.68
from -1.11
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 5.1M | 15.9M | 50.9M | |||
Avg | 4.7M | 11.1M | 34.1M | |||
Low | 4.3M | 6.9M | 11.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 108.7% | 240.5% | 356.6% | |||
Avg | 91.8% | 139.3% | 206.4% | |||
Low | 76.3% | 47.3% | -1.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -1.12 | -0.40 | -0.20 | |||
Avg | -1.11 | -0.68 | -0.44 | |||
Low | -1.09 | -0.82 | -0.65 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.